News
ASCO 2025 delivered pivotal updates. In this article, we discuss 8 of the more interesting abstracts from an investment ...
Treating patients with lung cancer always calls for a focus on informed and shared decision-making, according to expert ...
Dr Mariana Chavez MacGregor reports on advances from ASCO 2025, emphasizing treatment de-escalation and emerging tools like ctDNA for personalized care.
The first half of this year has been riddled with market volatility and geopolitical tension. But 2025’s American Society of ...
Breast cancer study results impressed at this year’s meeting, but raised new questions. Doctors also wrestled with how best ...
Karen Eubanks Jackson has reshaped the conversation around breast cancer for Black women in America—and now, with the ASCO ...
Dr. Joshua K. Sabari and Dr. Prantesh Jain delve into key lung cancer outcomes from the 2025 ASCO Meeting that patients should be aware of.
Brian P. Mulherin, MD, shares his key takeaways from the 2025 ASCO Annual Meeting, highlighting significant advancements in SCLC and the challenge of information overload at large conferences.
This is the web version of STAT’s special newslette r from the annual meeting of the American Society of Oncology. For more ...
This is the web version of STAT’s special newsletter from the annual meeting of the American Society of Oncology. For more ...
ASCO Data Shows New Therapy Extends Survival in Small Cell Lung Cancer. Here's what you need to know about the new ...
Each year, the American Society of Clinical Oncology annual meeting brings together the biggest names and brightest minds in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results